Name = adiponectin receptor 1
HGNCid = 24040
Symbol = ADIPOR1
EntrezGene = 51094
OMIM = 607945
RefSeq = NM_015999
UniProt = Q96A54
Chromosome = 1
Arm = q
Band = 32.1
LocusSupplementaryData = protein
Name = adiponectin receptor 2
HGNCid = 24041
Symbol = ADIPOR2
EntrezGene = 79602
OMIM = 607946
RefSeq = NM_024551
UniProt = Q86V24
Chromosome = 12
Arm = p
Band = 13
Adiponectin (also referred to as Acrp30, apM1) is a protein
hormonethat modulates a number of metabolic processes, including glucoseregulation and fatty acid catabolism. Adiponectin is exclusively secreted from adipose tissueinto the bloodstream and is very abundant in plasma relative to many hormones. Levels of the hormone are inversely correlated with body fat percentage in adults, while the association in infants and young children is more unclear. The hormone plays a role in the suppression of the metabolic derangements that may result in type 2 diabetes, obesity, atherosclerosisand non-alcoholic fatty liver disease(NAFLD).
Adiponectin was first characterised in mice as a transcript overexpressed in preadipocytes (precursors of fat cells) differentiating into
adipocytes. The human homologue was identified as the most abundant transcript in adipose tissue. Contrary to expectations, despite being produced in adipose tissue, adiponectin was found to be decreased in obesity. This downregulation has not been fully explained. The gene was localised to chromosome 3p27, a region highlighted as affecting genetic susceptibility to type 2 diabetes and obesity. Supplementation by differing forms of adiponectin were able to improve insulincontrol, blood glucose and triglyceride levels in mouse models.
The gene was investigated for variants that predispose to type 2 diabetes. Several
single nucleotide polymorphisms in the coding region and surrounding sequence were identified from several different populations, with varying prevalences, degrees of association and strength of effect on type 2 diabetes.
tructure and function
Adiponectin is a 244-amino-acid-long polypeptide. There are four distinct regions of adiponectin. The first is a short signal squence that targets the hormone for secretion outside the cell; next is a short region that varies between species; the third is a 65-amino acid region with similarity to collagenous proteins; the last is a globular domain. Overall this gene shows similarity to the complement 1Q factors. However, when the 3-dimensional structure of the globular region was determined, a striking similarity to TNFα was observed, despite unrelated protein sequences.
Adiponectin is secreted into the bloodsteam where it accounts for approximately 0.01% of all plasma protein at around 5-10 μg/mL. Plasma concentrations reveal a
sexual dimorphism, with females having higher levels than males. Levels of adiponectin are reduced in diabetics compared to non-diabetics. Weight reduction significantly increases circulating levels.
Adiponectin automatically self-associates into larger structures. Initially, three adiponectin molecules bind together to form a homotrimer. The
trimers continue to self-associate and form hexamers or dodecamers. Like the plasma concentration, the relative levels of the higher-order structures are sexually dimorphic, where females have increased proportions of the high-molecular weight forms. Questions remain about what the physiologically active forms of the protein are and how they carry out their action.
Adiponectin binds to a number of receptors. So far, two receptors have been identified, with homology to
G protein-coupled receptors. These have distinct tissue specificities within the body and have different affinities to the various forms of adiponectin. The receptors affect the downstream target AMP kinase, an important cellular metabolic rate control point. Expression of the receptors are correlated with insulin levels, as well as reduced in mouse models of diabetes, particularly in skeletal muscleand adipose tissue.
Adiponectin exerts some of its weight reduction effects via the
brain. This is similar to the action of leptin, but the two hormones perform complementary actions, and can have additive effects.
* glucose flux
* lipid catabolism
* protection from endothelial dysfunction (important facet of atherosclerotic formation)
* weight loss
Because adiponectin is a novel hormone, no therapy has yet been developed with adiponectin and it may be some years before
clinical trials commence. One obvious pharmaceutical treatment would be the administration of adiponectin; in mouse models such administration has shown positive effects. Problems to be overcome prior to human administration include establishing what the biologically active molecule is, what role post-translational modifications have upon the function and associated difficulties in generating biologically active molecules on a large scale. However, this remains a promising area of research for clinical therapy in diseases such as obesity, type 2 diabetes and fatty liver disease.
*cite journal | author=Ukkola O, Santaniemi M |title=Adiponectin: a link between excess adiposity and associated comorbidities? |journal=J. Mol. Med. |volume=80 |issue= 11 |pages= 696–702 |year= 2003 |pmid= 12436346 |doi= 10.1007/s00109-002-0378-7
*cite journal | author=Díez JJ, Iglesias P |title=The role of the novel adipocyte-derived hormone adiponectin in human disease |journal=Eur. J. Endocrinol. |volume=148 |issue= 3 |pages= 293–300 |year= 2003 |pmid= 12611609| doi=10.1530/eje.0.1480293
*cite journal | author=Vasseur F, Leprêtre F, Lacquemant C, Froguel P |title=The genetics of adiponectin |journal=Curr. Diab. Rep. |volume=3 |issue= 2 |pages= 151–8 |year= 2003 |pmid= 12728641| doi=10.1007/s11892-003-0039-4
*cite journal | author=Matsuzawa Y, Funahashi T, Kihara S, Shimomura I |title=Adiponectin and metabolic syndrome |journal=Arterioscler. Thromb. Vasc. Biol. |volume=24 |issue= 1 |pages= 29–33 |year= 2004 |pmid= 14551151 |doi= 10.1161/01.ATV.0000099786.99623.EF
*cite journal | author=Nedvídková J, Smitka K, Kopský V, Hainer V |title=Adiponectin, an adipocyte-derived protein |journal=Physiological research / Academia Scientiarum Bohemoslovaca |volume=54 |issue= 2 |pages= 133–40 |year= 2006 |pmid= 15544426 |doi=
*cite journal | author=Hug C, Lodish HF |title=The role of the adipocyte hormone adiponectin in cardiovascular disease |journal=Current opinion in pharmacology |volume=5 |issue= 2 |pages= 129–34 |year= 2005 |pmid= 15780820 |doi= 10.1016/j.coph.2005.01.001
*cite journal | author=Hara K, Yamauchi T, Kadowaki T |title=Adiponectin: an adipokine linking adipocytes and type 2 diabetes in humans |journal=Curr. Diab. Rep. |volume=5 |issue= 2 |pages= 136–40 |year= 2005 |pmid= 15794918| doi=10.1007/s11892-005-0041-0
*cite journal | author=Vasseur F, Meyre D, Froguel P |title=Adiponectin, type 2 diabetes and the metabolic syndrome: lessons from human genetic studies |journal=Expert reviews in molecular medicine |volume=8 |issue= 27 |pages= 1–12 |year= 2007 |pmid= 17112391 |doi= 10.1017/S1462399406000147
*cite journal | author=Menzaghi C, Trischitta V, Doria A |title=Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease |journal=Diabetes |volume=56 |issue= 5 |pages= 1198–209 |year= 2007 |pmid= 17303804 |doi= 10.2337/db06-0506
*cite journal | author=Lara-Castro C, Fu Y, Chung BH, Garvey WT |title=Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease |journal=Curr. Opin. Lipidol. |volume=18 |issue= 3 |pages= 263–70 |year= 2007 |pmid= 17495599 |doi= 10.1097/MOL.0b013e32814a645f
update_page = yes
require_manual_inspection = no
update_protein_box = yes
update_summary = no
update_citations = yes
Wikimedia Foundation. 2010.
Look at other dictionaries:
Adiponectin — Adiponektin Hexamer des Maus Adiponektin nach PDB … Deutsch Wikipedia
Adiponectin — A hormone secreted by fat cells (adipocytes) that affects the body s response to insulin and may have other important effects. Adipocytes produce and secrete a number of proteins. An adipose tissue specific factor was isolated that was termed… … Medical dictionary
adiponectin — noun A protein hormone that modulates glucose regulation and fatty acid catabolism … Wiktionary
adiponectin — adiponecˈtin noun A hormone secreted by fat tissue • • • Main Entry: ↑adipic … Useful english dictionary
ADIPOR1 — Adiponectin receptor 1, also known as ADIPOR1, is a human gene. PBB Summary section title = summary text = The adiponectin receptors, ADIPOR1 and ADIPOR2 (MIM 607946), serve as receptors for globular and full length adiponectin (MIM 605441) and… … Wikipedia
Adiponectine — L’adiponectine est une adipocytokine, c’est à dire une hormone produite par le tissu adipeux, qui est impliquée, entre autres, dans la régulation du métabolisme des lipides et du glucose. Structure cristallisée de l’ACRP30, une protéine de la… … Wikipédia en Français
Resistin — is a hormone secreted by adipose tissue. It is also known as serine/cysteine rich adipocyte Specific Secretory Factor (ADSF or FIZZ3). The length of the resistin pre peptide in human is 108 aminoacids (in the mouse and rat it s 114 aa); the… … Wikipedia
AMP-activated protein kinase — 5 AMP activated protein kinase or AMPK consists of three proteins (subunits) that together make a functional enzyme, conserved from yeast to humans, that plays a role in cellular energy homeostasis. It is expressed in a number of tissues,… … Wikipedia
APPL1 — Adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1, also known as APPL1, is a human gene.cite web | title = Entrez Gene: APPL1 adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper… … Wikipedia
Adiponectina — ADIPOQ adiponectin, C1Q and collagen domain containing HUGO 13633 Símbolo ADIPOQ Símbolos alt. ACDC; ADPN; APM1; APM 1; GB … Wikipedia Español